Sun Pharma’s Gujarat facility under USFDA import alert

PTI

Updated At : 02:23 PM Dec 09, 2022 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

New Delhi, December 8

Sun Pharmaceutical Industries on Thursday said its Halol facility in Gujarat has been listed under import alert by the USFDA.

The development follows an inspection of the facility by the US Food and Drug Administration (USFDA) from April 26 to May 9, 2022.

Import alert implies that all future shipments of products manufactured at this facility are subject to refusal of admission to the US market until it becomes compliant with current good manufacturing practice standards, it added.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles